General overview: biomarkers in neuroscience research

Area of Science:

• Neuroscience
• Biomarker Discovery
• Personalized Medicine

Background:

• Biomarkers are essential for disease diagnosis, treatment monitoring, and therapeutic development.
• Biomarker discovery in neuropsychiatric disorders is hindered by a lack of molecular correlates and significant interpatient heterogeneity.
• A multi-platform biomarker panel is necessary to accurately capture disease-related alterations in complex neuropsychiatric conditions.

Purpose of the Study:

• To highlight the challenges and requirements for effective biomarker discovery in neuroscience.
• To emphasize the need for a comprehensive approach integrating various methodologies and stakeholder efforts.

Main Methods:

• Utilizing animal models of psychiatric phenotypes.
• Employing omics (genomics, proteomics, etc.) and neuroimaging methodologies.
• Analyzing current limitations in sample handling, collection, and candidate biomarker validation.

Main Results:

• Current research faces limitations in standardization and interdisciplinary collaboration.
• Animal models and omics/imaging data are valuable but require careful integration.
• Addressing research gaps is critical for biomarker utility.

Conclusions:

• Overcoming challenges in biomarker discovery requires coordinated efforts from researchers, clinicians, and funding bodies.
• Standardization initiatives are vital for developing sensitive and specific biomarkers.
• Advancing personalized healthcare for neuropsychiatric disorders depends on successful biomarker development and implementation.